N-acetylcysteine as an adjunctive treatment for smoking cessation: a randomized clinical trial.

CONCLUSIONS: These findings highlight the need to associate N-acetylcysteine with first-line treatment for smoking cessation, since combined treatment may affect inflammation and metabolism components. CLINICAL TRIAL REGISTRATION: NCT02420418. PMID: 32725102 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32725102?dopt=Abstract

Source: Revista Brasileira de Psiquiatria - July 26, 2020 Category: Psychiatry Authors: Machado RCBR, Vargas HO, Baracat MM, Urbano MR, Verri WA, Porcu M, Nunes SOV Tags: Braz J Psychiatry Source Type: research